Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

COVID-19-free Palau could be among the first to reach herd immunity

By Brian Buntz | January 29, 2021

Palau

Image courtesy of Google

To date, in the U.S., some 6.5% of the population has received at least one COVID-19 vaccine dose. Alaska is currently the frontrunner in vaccinating its population. Almost 12% of Alaskans have received at least one dose.

But two U.S.-linked countries — Palau and American Samoa — have vaccinated more people per capita than any U.S. state. More than 17% of the inhabitants of Palau, a cluster of more than 500 islands east of the Philippines, have received at least one dose. For American Samoa, the same figure is 14.6%.

The U.S. territories, Guam and the Northern Mariana Islands have also administered more COVID-19 vaccine doses per capita than any U.S. state other than Alaska and West Virginia.

Palau (population 18,000) is noteworthy in that it has reported no COVID-19 cases to the World Health Organization. Neither had American Samoa.

Like Israel, Palau could also be among the first countries in the world to vaccinate the majority of its population. Palau’s Ministry of Health plans to have the majority of its population immunized by April.

The country has opted to primarily use the vaccine from Moderna (NSDQ:MRNA) as it does not have the ultracold storage requirements of the vaccine from Pfizer (NYSE:PFE). The island-nation, however, has acquired an ultracold freezer to accommodate up to 5,000 vaccine doses.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

This is the logo of Novartis.
Novartis breaks ground on North Carolina facility
Eli Lilly Huntsville Alabama Facility rendering (1)
Eli Lilly to build new $6B API manufacturing facility in Alabama
Thermo Fisher Scientific
Thermo Fisher expands investment in Asia bioprocessing for biopharma production
AstraZeneca
AstraZeneca to invest $2B in Maryland, support 2,600 jobs
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE